BlinatumomabDevelopment of drug resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1847卷 / 1期

关键词：

D O I：

10.1007/s40278-021-92658-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：101 / 101

相关论文

共 50 条

[41] WarfarinDevelopment of drug resistance: case report
Reactions Weekly, 2025, 2055 (1) : 342 - 342
[42] CotrimoxazoleDevelopment of drug resistance: case report
Reactions Weekly, 2020, 1823 (1) : 129 - 129
[43] RifampicinAcquired drug resistance: case report
Reactions Weekly, 2020, 1810 (1) : 182 - 182
[44] AntineoplasticsDevelopment of drug resistance: case report
Reactions Weekly, 2019, 1782 (1) : 37 - 37
[45] ImatinibDevelopment of drug resistance: case report
Reactions Weekly, 2021, 1866 (1) : 209 - 209
[46] DolutegravirAcquired drug resistance: case report
Reactions Weekly, 2023, 1962 (1) : 165 - 165
[47] IsoniazidDevelopment of drug resistance: case report
Reactions Weekly, 2021, 1874 (1) : 150 - 150
[48] LorlatinibDevelopment of drug resistance: case report
Reactions Weekly, 2019, 1771 (1) : 193 - 193
[49] AfatinibAcquired drug resistance : case report
Reactions Weekly, 2022, 1912 (1) : 21 - 21
[50] AlectinibAcquired drug resistance: case report
Reactions Weekly, 2023, 1960 (1) : 24 - 24

← 1 2 3 4 5 →